SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-02
👔
Monopar Therapeutics
@MNPR_InsiderForm 4 Filing: Cittadine Andrew Surrenders for Taxes $213,790.31 of $MNPR
TAX WITHHOLDING
⚡ MATERIALITY: 3/10
corporate issuer
Monopar Therapeutics
Ticker: $MNPR
Transaction Value
$213,790.31
Price/Share: $28.27
transaction date
2026-06-30
Shares: 7,563
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Cittadine Andrew, holds the title of Chief Operating Officer at Monopar Therapeutics.
On 2026-06-30, the insider transacted 7,563 shares.The shares were transacted at a weighted average price of $28.27 per share, resulting in a total market-relevant value of $213,790.31.
Executive Summary Summary
Cittadine Andrew (Chief Operating Officer) had withheld for taxes $214K of $MNPR
Post-Transaction Position: 55,614 shares
SEC Accession No: 0001437749-26-022628 (CIK: 1863624)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.